Cargando…

Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?

Recent studies indicate that cancer antigen 125 (CA125) response criteria tend to overestimate a tumour reduction measured by standard WHO response criteria in recurrent epithelial ovarian carcinoma. The aim of the study was to validate the recently introduced GCIG (The Gynaecological Cancer Intergr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gronlund, B, Hansen, H H, Høgdall, C, Høgdall, E V S, Engelholm, S A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409573/ https://www.ncbi.nlm.nih.gov/pubmed/14735180 http://dx.doi.org/10.1038/sj.bjc.6601501

Ejemplares similares

CA125 in ovarian tumour tissue at second laparotomy.
por: Maughan, T. S., et al.
Publicado: (1989)

Organoids and epithelial ovarian cancer - a future tool for personalized treatment decisions? (Review)
por: Sisman, Yagmur, et al.
Publicado: (2022)

MicroRNA characteristics in epithelial ovarian cancer
por: Prahm, Kira Philipsen, et al.
Publicado: (2021)

The prevalence of EBV and CMV DNA in epithelial ovarian cancer
por: Ingerslev, Kasper, et al.
Publicado: (2019)

Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
por: Oliveira, Douglas V. N. P., et al.
Publicado: (2021)

Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases
por: Oliveira, Douglas V. N. P., et al.
Publicado: (2020)

CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial
por: Alexandre, J, et al.
Publicado: (2012)

Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer
por: Prahm, Kira Philipsen, et al.
Publicado: (2018)

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
por: Wohlmuth, Christoph, et al.
Publicado: (2022)

High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population
por: Ingerslev, Kasper, et al.
Publicado: (2016)

Strategies for data normalization and missing data imputation and consequences for potential diagnostic microRNA biomarkers in epithelial ovarian cancer
por: Lopacinska-Jørgensen, Joanna, et al.
Publicado: (2023)

Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer
por: Lopacinska-Jørgensen, Joanna, et al.
Publicado: (2021)

Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients
por: Wilbaux, M, et al.
Publicado: (2014)

Outstanding Response to Sorafenib in a Patient with Metastatic Gastrointestinal Stromal Tumour
por: Brinch, Charlotte, et al.
Publicado: (2021)

The Value of CA 125 and CA72-4 in Management of Patients with Epithelial Ovarian Cancer
por: Fayed, Salah T., et al.
Publicado: (1998)

Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients
por: Petersen, Patrick H.D., et al.
Publicado: (2023)

SAT-125 Underestimation of the Prevalence of Diabetes and Overestimation of the Prevalence of Glucose Tolerance by Using Hemoglobin A1c Criteria
por: Chang Villacreses, Maria Mercedes, et al.
Publicado: (2019)

The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis
por: Ingerslev, Kasper, et al.
Publicado: (2017)

Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.
por: Halila, H., et al.
Publicado: (1987)

The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma.
por: Hawkins, R. E., et al.
Publicado: (1989)

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.
por: Fisken, J., et al.
Publicado: (1993)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
por: Winarno, G. N. A., et al.
Publicado: (2020)

Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project
por: Hentze, Julie L., et al.
Publicado: (2017)

Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures
por: Oliveira, Douglas V. N. P., et al.
Publicado: (2021)

Potential Targeted Therapies in Ovarian Cancer
por: Sisman, Yagmur, et al.
Publicado: (2022)

Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker
por: Sánchez Vega, Juan Fernando, et al.
Publicado: (2018)

Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass
por: Oliveira, Douglas Nogueira Perez, et al.
Publicado: (2019)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer
por: Anastasi, Emanuela, et al.
Publicado: (2013)

Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer
por: Chen, Jie-Ping, et al.
Publicado: (2019)

DNA Methylation in Ovarian Tumors—a Comparison Between Fresh Tissue and FFPE Samples
por: Oliveira, Douglas V.N.P., et al.
Publicado: (2021)

Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer
por: Koh, Stephen Chee Liang, et al.
Publicado: (2012)

Can CA-125 Predict Lymph Node Metastasis in Epithelial Ovarian Cancers in Turkish Population?
por: Sudolmuş, Sinem, et al.
Publicado: (2014)

Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imaging
por: Sharma, Sai Kiran, et al.
Publicado: (2014)

Are ROMA and HE4 More Accurate than CA-125, in Predicting of Ovarian Epithelial Carcinoma?
por: Behnamfar, Fariba, et al.
Publicado: (2023)

Serum CA125, CA199 and CEA Combined Detection for Epithelial Ovarian Cancer Diagnosis: A Meta-analysis
por: Guo, Junhong, et al.
Publicado: (2017)

Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancer.
por: Venesmaa, P., et al.
Publicado: (1994)

Is the Cardiopulmonary Bypass Systemic Inflammatory Response Overestimated?
por: Evora, Paulo Roberto B., et al.
Publicado: (2018)

Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction
por: Idorn, Manja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_scbgl6gc7v0btk5lvsnhd5p42m